相关实验视频
Updated: May 30, 2025

12:24
Murine Model of CD40-activation of B cells
Published on: March 5, 2010
12.6K
CD20和CD19促进由IgM-TLR9-L265P MyD88复合体驱动的扩散
Yohei Kobayashi1, Ryota Sato1, Yuri Shimizu1
1Division of Innate Immunity, The Institute of Medical Science, The University of Tokyo; Minato-ku, Tokyo 108-8639, Japan.
International immunology
|January 27, 2025
概括
MyD88 L265P突变通过形成My-T-BCR复合体,驱动激活B细胞扩散大B细胞淋巴瘤 (ABC DLBCL) 的增殖. CD19和CD20通过不同的机制增强这种增殖,影响B细胞淋巴瘤的生长.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- L265P MyD88突变是大约30%的激活B细胞样扩散大B细胞淋巴瘤 (ABC DLBCL) 病例的关键驱动因素.
- 这种突变导致My-T-BCR复合体的形成,涉及MyD88,Toll-like受体9 (TLR9) 和B细胞受体 (BCR) 组件,如IgM,驱动恶性细胞增殖.
研究的目的:
- 研究B细胞表面分子CD19和CD20在调节由ABC DLBCL中My-T-BCR复合体驱动的增殖中的作用.
- 阐明CD19和CD20影响My-T-BCR复合物中介增殖的独特机制.
主要方法:
- 利用了依赖IL-3 (IL-3) 的Ba/F3细胞系,该细胞系被设计成表达IgM复合体 (IgM,CD79a,CD79b) 和TLR9.9.
- 在具有或没有L265P MyD88,CD19和CD20的细胞中对抗IgM抗体和TLR9连接体 (CpG-B) 的反应中评估的增殖.
- 检查了信号通路,包括AKT酸化和细胞表面分子表达,以应对这些刺激.
主要成果:
- CD19特别增强了IgM和TLR9调解的L265PMyD88表达细胞的增殖,并促进了依赖IgM的AKT酸化.
- CD20在野生类型和L265P MyD88表达细胞中增强了增殖,通过增加细胞表面IgM表达,在L265P MyD88细胞中独特地实现了IgM介导的增殖.
- 在ABC DLBCL细胞系TMD8中破坏CD19,CD20或TLR9受损的抗IgM抗体介导生长.
结论:
- CD19和CD20在促进ABC DLBCL中My-T-BCR复合体驱动的增殖中起着不同的作用.
- CD19主要影响复合体下游的信号传输,而CD20通过增加IgM表达来增强复合体形成.
- 这些发现凸显了CD19和CD20作为L265P MyD88突变的ABC DLBCL的潜在治疗点.
相关概念视频
T Cell Activation and Clonal Selection
643
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
643
B Cell Activation and Differentiation
1.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.6K
Cells of the Adaptive Immune Response
944
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
944
Cytotoxic T Cells-mediated Immune Response
835
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
835
Cell-mediated Immune Responses
66.7K
Overview
66.7K
Antigens Involved in Adaptive Immunity
446
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
446

